
TSE:ARE
This summary was created by AI, based on 18 opinions in the last 12 months.
Aecon Group Inc. (ARE-T) stands out in the Canadian construction and infrastructure market, particularly with its significant involvement in nuclear projects, which is gaining traction alongside infrastructure investments in Canada. Analysts emphasize the company’s substantial backlog, which has reached record levels, indicating future revenue growth potential. However, there are concerns regarding market volatility and thin profit margins prevalent in the construction industry. Experts suggest a shift in management focus towards more sustainable variable-price contracts, helping to alleviate the impacts of legacy fixed-price contracts that have historically plagued the company. Overall, while some analysts express caution regarding short-term fluctuations, many are optimistic about the long-term prospects driven by increasing infrastructure spending and growth in nuclear energy projects.
ARE-T vs. BIP.UN-T. He is happy with both. In terms of catalysts, ARE-T looks to be the more undervalued of the two. He thinks things will get more positive for it after the pandemic. It is a smaller company and could move farther. BIP.UN-T bought cell phone towers in India and are trying to take over IPL-T. He would average in to either one.
She has WSP-T instead because it is only a consulting company. Construction is where these companies would get into problems. WSP-N just bought a company in environmental services in the US and this is a very attractive market to be in. She would buy it after a pull back.
Puzzling. ARE wasn't effected either way by the pandemic. They had a $7.5 billion backlog, an all-time high when the stock is at a 5-year low. Puzzling why this stock hasn't taken off. Perhaps the confessions on the Bermuda airport and Toronto's Eglinton LRT project have hurt them, but will be valuable down the road. Their base business is growing profits, revenues and cash flow. Pays over a 4% dividend. ARE is overlooked. (Analysts’ price target is $19.95)